Sort
40,608 grants matching “prostate cancer”
Evaluatiing the accuracy of complex screening or diagnostic procedures
$413,785Binbing Yu · National Institute On Aging · ZIC · FY2011 · AG
Targeting KDM4B, a novel alternative splicing regulator, in castration-resistant prostate cancer (CRPC)
$413,776Zhi-Ping Liu · Ut Southwestern Medical Center · R01 · FY2021 · CA
Elucidating the Mechanisms of Racial and Ethnic Disparities in Dialysis Quality
$413,750Eugene Lin · University Of Southern California · R01 · FY2023 · DK
INCREASING ACCESS TO CLINICAL AND EDUCATIONAL STUDIES
$413,737Thomas Jefferson University · U01 · FY2003 · CA
Macrophages induce a tumor-promoting stable EMT in prostate cancer
$413,728Kenneth J. Pienta · University Of Michigan At Ann Arbor · P01 · FY2019 · CA
MULTIVALENT PEPTIDOMIMETIC CONJUGATES AS INHIBITORS OF ANDROGEN RECEPTOR FUNCTION IN THERAPY-RESISTANT PROSTATE CANCER
$413,723New York University · · FY2015 · Department of the Army
Molecular Targets for Cancer Detection and Treatment
$413,715Johns Hopkins University · T32 · FY2001 · CA
Understanding the influence of bone-metastatic prostate cancer and mesenchymal stromal cells on γδ T cells, in the bone microenvironment.
$413,715Daniel Abate-Daga · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer
$413,691Qianben Wang · Duke University · R01 · FY2021 · CA
Metabolic Imaging of the Prostate Using 3D MRSI
$413,674University Of California San Francisco · R01 · FY2001 · CA
Improving prostate biopsy efficiency: The finasteride challenge test
$413,631Javier Hernandez · University Of Texas Hlth Science Center · R01 · FY2013 · CA
Germline modifiers of tumor progression and metastasis in prostate cancer
$413,581Nigel Crawford · National Human Genome Research Institute · ZIA · FY2013 · HG
PRECISE MRI DIRECTED SONIC ABLATION OF PROSTATE CANCER
$413,514Stanford University · R33 · FY2001 · CA
Reversing epithelial-mesenchymal transition in metastatic cancer cells using engineered nanomaterials and a mild photothermal effect
$413,479Congzhou Wang · South Dakota School Of Mines And Techn'Y · R15 · FY2022 · CA
Biomechanical Regulation of Organ Growth
$413,466Kenneth D Irvine · Rutgers, The State Univ Of N.J. · R01 · FY2017 · GM
Biomechanical Regulation of Organ Growth
$413,466Kenneth D Irvine · Rutgers, The State Univ Of N.J. · R01 · FY2018 · GM
Shared Resource: Therapeutic Manufacturing
$413,458Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2017 · CA
Research & Methods Core
$413,452Katherine S Panageas · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
ROLE FOR A STEROID SULFONTRANSFERASE (SULT2B) IN THE INTRATUMORAL ANDROGEN METABOLISM AND IN PROSTATE CANCER
$413,423Foundation For Advancing Veterans Health Research · · FY2014 · Department of the Army
Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies
$413,415Ying Huang · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
PROMOTING HEALTH IN PROSTATE &BREAST CANCER
$413,404Duke University · R01 · FY2003 · CA
Dual Targeting of AR and HIF1 to promote radiosensitization of prostate cancer
$413,366James M Larner · University Of Virginia · R01 · FY2018 · CA
HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C
$413,330Neal Rosen · Sloan-Kettering Inst Can Research · P50 · FY2007 · CA
Metabolic Imaging of the Prostate Using 3D MRSI
$413,327University Of California San Francisco · R01 · FY2003 · CA
Stanford Cancer Imaging Training (SCIT) Program
$413,296Jeremy Dahl · Stanford University · T32 · FY2023 · CA